Chandra Bhagat Pharma Ltd (542934)
- Market Cap
- ₹37
- P/B Ratio
- 1.13
- Debt/Equity
- 0.50
- Promoter
- 73.0%
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2026 | Mar 2026 |
|---|---|---|
| Equity Capital | 8 | 8 |
| Reserves | 26 | 23 |
| Borrowings | 17 | 21 |
| Total Liabilities | 94 | 88 |
| Fixed Assets | 3 | 2 |
| Investments | 2 | 1 |
| Total Assets | 94 | 88 |
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +9 |
| Investing | -0 |
| Financing | -6 |
| Net Cash Flow | +2 |
👥 Shareholding Pattern
| Category | Q2FY25 | Q4FY25 | Q2FY26 | Q4FY26 |
|---|---|---|---|---|
| Promoters | 69.3% | 71.2% | 72.2% | 73.0% |
| FII | 0.5% | 0.6% | 0.6% | 0.0% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% |
| Public | 12.8% | 11.2% | 11.8% | 11.3% |
| # Shareholders | 315 | 316 | 301 | 280 |
⚖️ Peer Comparison — Pharmaceuticals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| SUNPHARMA | 4.37 L Cr | 36.1 | 18.7% | — | 0.05 |
| DIVISLAB | 2.46 L Cr | 84.2 | 23.0% | — | 0.00 |
| TORNTPHARM | 1.83 L Cr | 76.6 | 15.1% | — | 1.76 |
| ZYDUSLIFE | 1.16 L Cr | 25.9 | 16.8% | — | 0.43 |
| CIPLA | 1.09 L Cr | 32.3 | 13.2% | — | 0.01 |
| LAURUSLABS | 1.07 L Cr | 97.8 | 20.8% | — | 0.45 |
| MANKIND | 1.03 L Cr | 50.6 | 13.9% | — | 0.38 |
| DRREDDY | 1.03 L Cr | 31.9 | 10.1% | — | 0.17 |
| AUROPHARMA | 95,887 | 26.0 | 12.8% | — | 0.20 |
| LUPIN | 93,367 | 16.5 | 27.9% | — | 0.26 |
🔗 Peer Stock Analyses
📋 Recent Filings
- 🔴 Announcement2026-09-30Chandra Bhagat Pharma announced the resignation of Company Secretary Rajani Dawani effective September 30, 2026, citing personal reasons and pursuit o…
- 🟡 voting results2026-09-03At the September 3, 2026 AGM, shareholders approved all four resolutions including adoption of annual accounts, reappointment of Praanav Bhagat, incre…
- 🟡 Board Meeting2026-09-01Chandra Bhagat Pharma held its 23rd AGM on September 1, 2026, confirming quorum and approving key resolutions including adoption of annual accounts, r…
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day